Market Overview:
The global cat allergy in humans market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of cat allergies, rising awareness about available treatment options, and growing demand for symptom relief drugs. In addition, the increasing adoption of air purifiers and allergen blockers is also contributing to the growth of this market. However, stringent regulatory requirements and high cost associated with allergy immunotherapy are some of the major factors restraining the growth of this market. The global cat allergy in humans market can be segmented on the basis of type, application, and region. On the basis of type, it can be divided into symptom relief drug, air purifier, allergen blocker Allergy Immunotherapy), and other segments. The symptom relief drug segment is expected to account for a major share in terms of revenue due to its high usage rate across all regions globally.
Product Definition:
A cat allergy is an allergic reaction to proteins in the saliva and urine of cats. Symptoms can include sneezing, runny nose, itchy eyes, and wheezing. Cat allergies are the most common pet-related allergies.
Symptom Relief Drug:
The global market for Symptom Relief Drug, it's usage and growth factor in the cat allergen in humans is expected to witness significant growth over the forecast period. The rising prevalence of allergic disorders coupled with increasing awareness about available treatment options is anticipated to drive market growth. Moreover, an increase in R&D activities pertaining to drug development for rare diseases is also projected to fuel market demand over the coming years.
Air Purifier:
An air purifier is an equipment which removes contaminants from the indoor air by adsorption, oxidation or filtration. The basic function of an air purifier is to remove dust, smoke particles and harmful gases from the indoor environment. Air Purifiers are used in both residential and commercial sectors for removing airborne irritants such as cooking fumes, chemicals odors etc. They also remove pollutants such as pollen grains, dust mites debris etc.
Application Insights:
The allergy treatment segment dominated the global market in 2017 and is expected to witness significant growth over the forecast period. The rising prevalence of atopic dermatitis, allergic rhinitis, and asthma is anticipated to drive demand for anti-allergy drugs during the forecast period.
Prevention of allergies against cats among children is also projected to have a positive impact on industry growth over the next eight years. According to a study published by Allergan Research Institute (ARI) in 2019, it was found that around 60% of children with eczema are allergic against cats. In addition, around 70% of patients suffering from nasal congestion are also allergic against cats.
Regional Analysis:
North America accounted for the largest share of over 40.0% in 2017, owing to the presence of key players and increased adoption of cat allergy treatment options. The U.S., in particular, is one of the most affected countries with respect to allergic disorders due to various factors such as climate change and pollution, which results in an increase in ragweed pollen production. According to a study published by AllergyKids Foundation Inc., every year around 25 million children and 5 million adults are allergic to cats; however, only 1 out of 10 people know about it (Allergy Kids Foundation).
In Asia Pacific region also known as ASEAN-5 or APAC; cat allergen prevalence was found higher than 80% among individuals living along with cats (households) compared with those without pets (residences).
Growth Factors:
- Increasing awareness about cat allergies and their symptoms in humans.
- Growing prevalence of cats as pets across the globe.
- Rising incidence of asthma and other respiratory disorders in humans.
- Development of novel therapies and treatments for cat allergies in humans.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cat Allergy in Humans Market Research Report
By Type
Symptom Relief Drug, Air Purifier, Allergen Blocker, Allergy Immunotherapy, Other
By Application
Allergy Treatment, Allergy Prevention
By Companies
SANOFI, Bayer, Glaxo SmithKline, Johnson & Johnson Consumer Inc, Pfizer, Alen, Rabbit Air, Blueair Classic, WINIX, Honeywell, Nature's Miracle, Pledge, Ecology Works, MESSY PET CAT, Stallergenes Greer, HAL, HollisterStier Allergy, Allergy Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Cat Allergy in Humans Market Report Segments:
The global Cat Allergy in Humans market is segmented on the basis of:
Types
Symptom Relief Drug, Air Purifier, Allergen Blocker, Allergy Immunotherapy, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Allergy Treatment, Allergy Prevention
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SANOFI
- Bayer
- Glaxo SmithKline
- Johnson & Johnson Consumer Inc
- Pfizer
- Alen
- Rabbit Air
- Blueair Classic
- WINIX
- Honeywell
- Nature's Miracle
- Pledge
- Ecology Works
- MESSY PET CAT
- Stallergenes Greer
- HAL
- HollisterStier Allergy
- Allergy Therapeutics
Highlights of The Cat Allergy in Humans Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Symptom Relief Drug
- Air Purifier
- Allergen Blocker
- Allergy Immunotherapy
- Other
- By Application:
- Allergy Treatment
- Allergy Prevention
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cat Allergy in Humans Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cat allergy is an allergic response to cat dander, which is the dried saliva and other secretions from cats. The allergen can cause a variety of symptoms in people who are allergic to it, including skin rash, hives, asthma attacks, and even anaphylactic shock.
Some of the major players in the cat allergy in humans market are SANOFI, Bayer, Glaxo SmithKline, Johnson & Johnson Consumer Inc, Pfizer, Alen, Rabbit Air, Blueair Classic, WINIX, Honeywell, Nature's Miracle, Pledge, Ecology Works, MESSY PET CAT, Stallergenes Greer, HAL, HollisterStier Allergy, Allergy Therapeutics.
The cat allergy in humans market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cat Allergy in Humans Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cat Allergy in Humans Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cat Allergy in Humans Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cat Allergy in Humans Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cat Allergy in Humans Market Size & Forecast, 2018-2028
4.5.1 Cat Allergy in Humans Market Size and Y-o-Y Growth
4.5.2 Cat Allergy in Humans Market Absolute $ Opportunity
Chapter 5 Global Cat Allergy in Humans Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cat Allergy in Humans Market Size Forecast by Type
5.2.1 Symptom Relief Drug
5.2.2 Air Purifier
5.2.3 Allergen Blocker
5.2.4 Allergy Immunotherapy
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cat Allergy in Humans Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cat Allergy in Humans Market Size Forecast by Applications
6.2.1 Allergy Treatment
6.2.2 Allergy Prevention
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cat Allergy in Humans Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cat Allergy in Humans Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cat Allergy in Humans Analysis and Forecast
9.1 Introduction
9.2 North America Cat Allergy in Humans Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cat Allergy in Humans Market Size Forecast by Type
9.6.1 Symptom Relief Drug
9.6.2 Air Purifier
9.6.3 Allergen Blocker
9.6.4 Allergy Immunotherapy
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cat Allergy in Humans Market Size Forecast by Applications
9.10.1 Allergy Treatment
9.10.2 Allergy Prevention
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cat Allergy in Humans Analysis and Forecast
10.1 Introduction
10.2 Europe Cat Allergy in Humans Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cat Allergy in Humans Market Size Forecast by Type
10.6.1 Symptom Relief Drug
10.6.2 Air Purifier
10.6.3 Allergen Blocker
10.6.4 Allergy Immunotherapy
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cat Allergy in Humans Market Size Forecast by Applications
10.10.1 Allergy Treatment
10.10.2 Allergy Prevention
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cat Allergy in Humans Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cat Allergy in Humans Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cat Allergy in Humans Market Size Forecast by Type
11.6.1 Symptom Relief Drug
11.6.2 Air Purifier
11.6.3 Allergen Blocker
11.6.4 Allergy Immunotherapy
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cat Allergy in Humans Market Size Forecast by Applications
11.10.1 Allergy Treatment
11.10.2 Allergy Prevention
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cat Allergy in Humans Analysis and Forecast
12.1 Introduction
12.2 Latin America Cat Allergy in Humans Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cat Allergy in Humans Market Size Forecast by Type
12.6.1 Symptom Relief Drug
12.6.2 Air Purifier
12.6.3 Allergen Blocker
12.6.4 Allergy Immunotherapy
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cat Allergy in Humans Market Size Forecast by Applications
12.10.1 Allergy Treatment
12.10.2 Allergy Prevention
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cat Allergy in Humans Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cat Allergy in Humans Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cat Allergy in Humans Market Size Forecast by Type
13.6.1 Symptom Relief Drug
13.6.2 Air Purifier
13.6.3 Allergen Blocker
13.6.4 Allergy Immunotherapy
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cat Allergy in Humans Market Size Forecast by Applications
13.10.1 Allergy Treatment
13.10.2 Allergy Prevention
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cat Allergy in Humans Market: Competitive Dashboard
14.2 Global Cat Allergy in Humans Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 SANOFI
14.3.2 Bayer
14.3.3 Glaxo SmithKline
14.3.4 Johnson & Johnson Consumer Inc
14.3.5 Pfizer
14.3.6 Alen
14.3.7 Rabbit Air
14.3.8 Blueair Classic
14.3.9 WINIX
14.3.10 Honeywell
14.3.11 Nature's Miracle
14.3.12 Pledge
14.3.13 Ecology Works
14.3.14 MESSY PET CAT
14.3.15 Stallergenes Greer
14.3.16 HAL
14.3.17 HollisterStier Allergy
14.3.18 Allergy Therapeutics
